Group Testing with Homophily to Curb Epidemics with Asymptomatic Carriers
Louis-Marie Harpedanne de Belleville
doi: https://doi.org/10.1101/2020.10.09.20210260
Louis-Marie Harpedanne de Belleville
Paris School of Economics, Université Paris 1 Panthéon-Sorbonne and Banque de France
Data Availability
No data: mathematical analysis
Posted October 31, 2020.
Group Testing with Homophily to Curb Epidemics with Asymptomatic Carriers
Louis-Marie Harpedanne de Belleville
medRxiv 2020.10.09.20210260; doi: https://doi.org/10.1101/2020.10.09.20210260
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)